Infection and Immunity

Journal

Publication Venue For

  • Cooperativity between stenotrophomonas maltophilia and pseudomonas aeruginosa during polymicrobial airway infections.  88. 2020
  • Mosquito bite-induced controlled human malaria infection with Plasmodium vivax or P. Falciparum generates immune responses to homologous and heterologous preerythrocytic and erythrocytic antigens.  87. 2019
  • Autoinducer 2 (AI-2) production by nontypeable haemophilus influenzae 86-028NP promotes expression of a predicted glycosyltransferase that is a determinant of biofilm maturation, prevention of dispersal, and persistence in vivo.  86. 2018
  • Role of common γ-Chain cytokines in lung interleukin-22 regulation after acute exposure to aspergillus fumigatus.  86. 2018
  • Novel immunoprotective proteins of Streptococcus pneumoniae identified by opsonophagocytosis killing screen.  86. 2018
  • Terminal deoxynucleotidyl transferase is not required for antibody response to polysaccharide vaccines against Streptococcus pneumoniae and Salmonella enterica serovar Typhi.  86. 2018
  • Acidic mammalian chitinase negatively affects immune responses during acute and chronic Aspergillus fumigatus exposure.  86. 2018
  • Glucan binding protein C of Streptococcus mutans mediates both sucrose-independent and sucrose-dependent adherence.  86. 2018
  • Activation of the innate immune system by Treponema denticola periplasmic flagella through Toll-like receptor 2.  86. 2018
  • Cell invasion and pyruvate oxidase-derived H 2 O 2 are critical for Streptococcus pneumoniae-mediated cardiomyocyte killing.  86. 2018
  • Correction: "Activation of the innate immune system by Treponema denticola periplasmic flagella through Toll-like receptor 2" [Infection and Immunity, 86, 1, e00573-17, (2018)] doi: 10.1128/IAI.00573-17.  86. 2018
  • Haemophilus parainfluenzae strain ATCC 33392 forms biofilms in vitro and during experimental otitis media infections.  85. 2017
  • Phenotype and function of myeloidderived suppressor cells induced by Porphyromonas gingivalis infection.  85. 2017
  • Position of O-acetylation within the capsular repeat unit impacts the biological properties of pneumococcal serotypes 33A and 33F.  85. 2017
  • Pneumococcal neuraminidase A (NanA) promotes biofilm formation and synergizes with influenza A virus in nasal colonization and middle ear infection.  85. 2017
  • Infiltrated macrophages die of pneumolysin-mediated necroptosis following pneumococcal myocardial invasion.  84:1457-1469. 2016
  • Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells.  84:1941-1956. 2016
  • Discovery and characterization of human-urine utilization by asymptomaticbacteriuria-causing Streptococcus agalactiae.  84:307-319. 2016
  • Free sialic acid acts as a signal that promotes streptococcus pneumoniae invasion of nasal tissue and nonhematogenous invasion of the central nervous system.  84:2607-2615. 2016
  • Neuraminidase A-exposed galactose promotes Streptococcus pneumoniae biofilm formation during colonization.  84:2922-2932. 2016
  • A small molecule, odanacatib, inhibits inflammation and bone loss caused by endodontic disease.  83:1235-1245. 2015
  • Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model.  83:214-226. 2015
  • Enterococcus faecalis 6-phosphogluconolactonase is required for both commensal and pathogenic interactions with Manduca sexta.  83:396-404. 2015
  • Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.  83:108-119. 2015
  • Oral streptococci and nitrite-mediated interference of Pseudomonas aeruginosa.  83:101-107. 2015
  • Peroxiredoxin-glutaredoxin and catalase promote resistance of nontypeable Haemophilus influenzae 86-028NP to oxidants and survival within neutrophil extracellular traps.  83:239-246. 2015
  • Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumonia.  83:614-624. 2015
  • The omentum is a site of protective IgM production during intracellular bacterial infection.  83:2139-2147. 2015
  • Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation..  82:4802-4812. 2014
  • Eosinophil deficiency compromises lung defense against Aspergillus fumigatus.  82:1315-1325. 2014
  • Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection.  82:1326-1334. 2014
  • Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.  82:364-370. 2014
  • Suppression of antimicrobial peptide expression by Ureaplasma species.  82:1657-1665. 2014
  • Dectin immunoadhesins and Pneumocystis pneumonia.  81:3451-3462. 2013
  • Nanogel-based pspa intranasal vaccine prevents invasive disease and nasal colonization by streptococcus pneumoniae.  81:1625-1634. 2013
  • Quiescent Innate Response to Infective Filariae by Human Langerhans Cells Suggests aStrategy of Immune Evasion.  81:1420-1429. 2013
  • Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor.  81:1316-1324. 2013
  • PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization.  81:173-181. 2013
  • Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.  80:3145-3160. 2012
  • Roles of inflammatory caspases during processing of zebrafish interleukin-1β in Francisella noatunensis infection.  80:2878-2885. 2012
  • Microbicidal activity of vascular peroxidase 1 in human plasma via generation of hypochlorous acid.  80:2528-2537. 2012
  • Pneumococcal gene complex involved in resistance to extracellular oxidative stress.  80:1037-1049. 2012
  • Dectin-1-dependent interleukin-22 contributes to early innate lung defense against aspergillus fumigatus.  80:410-417. 2012
  • Neutrophils produce interleukin 17A (IL-17A) in a Dectin-1- and IL-23-dependent manner during invasive fungal infection.  79:3966-3977. 2011
  • Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.  79:3792-3800. 2011
  • Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model.  79:3087-3095. 2011
  • Erratum: Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.  79:3472. 2011
  • New cell surface protein involved in biofilm formation by Streptococcus parasanguinis.  79:3239-3248. 2011
  • The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.  79:2819-2828. 2011
  • Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.  79:2440-2450. 2011
  • Malaria immunoepidemiology in low transmission: Correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3.  79:2070-2078. 2011
  • Nontypeable haemophilus influenzae initiates formation of neutrophil extracellular traps.  79:431-438. 2011
  • Older adults have a low capacity to opsonize pneumococci due to low igm antibody response to pneumococcal vaccinations.  79:314-320. 2011
  • Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.  78:3129-3135. 2010
  • Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.  78:2620-2630. 2010
  • The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.  78:2163-2172. 2010
  • Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.  78:1185-1192. 2010
  • Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups (Infection and Immunity (2009) 77, 8, (3374-3379)).  78:1414. 2010
  • Comprehensive evaluation of Streptococcus sanguinis cell wall-anchored proteins in early infective endocarditis.  77:4966-4975. 2009
  • Complement C3 plays an essential role in the control of opportunistic fungal infections.  77:3679-3685. 2009
  • LuxS promotes biofilm maturation and persistence of nontypeable Haemophilus influenzae in vivo via modulation of lipooligosaccharides on the bacterial surface.  77:4081-4091. 2009
  • Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.  77:3374-3379. 2009
  • The absence of Hck, Fgr, and lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.  77:1790-1797. 2009
  • Host immune response and acute disease in a zebrafish model of francisella pathogenesis.  77:914-925. 2009
  • Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.  77:464-471. 2009
  • The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.  77:399-404. 2009
  • A conserved C-terminal 13-amino-acid motif of Gap1 Is Required for Gap1 Function and Necessary for the Biogenesis of a Serine-Rich Glycoprotein of Streptococcus parasanguinis.  76:5624-5631. 2008
  • Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema.  76:4959-4967. 2008
  • Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.  76:2767-2776. 2008
  • Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.  76:2037-2043. 2008
  • Lipoteichoic acid is important in innate immune responses to gram-positive bacteria.  76:206-213. 2008
  • Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.  75:5930-5938. 2007
  • Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.  75:5956-5966. 2007
  • PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.  75:5877-5885. 2007
  • Treponema denticola activates mitogen-activated protein kinase signal pathways through toll-like receptor 2.  75:5763-5768. 2007
  • Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.  75:5460-5464. 2007
  • Genetic basis for the new pneumococcal serotype, 6C.  75:4482-4489. 2007
  • Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.  75:4127-4137. 2007
  • National institute of allergy and infectious diseases bioinformatics resource centers: New assets for pathogen informatics.  75:3212-3219. 2007
  • The glycan moieties and the N-terminal polypeptide backbone of a fimbria-associated adhesin, Fap1, play distinct roles in the biofilm development of Streptococcus parasanguinis.  75:2181-2188. 2007
  • Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.  75:1843-1851. 2007
  • Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.  75:1453-1462. 2007
  • Phosplioiylclioline decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.  75:958-965. 2007
  • Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.  75:350-357. 2007
  • The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor.  74:5382-5390. 2006
  • Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease.  74:4766-4777. 2006
  • Cell wall-mediated neuronal damage in early sepsis.  74:3783-3789. 2006
  • Erratum: β-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae (Infection and Immunity (2005) 73, 12 (7827-7835)).  74:3078. 2006
  • How the bacterial pathogen Listeria monocytogenes mediates the switch from environmental Dr. Jekyll to pathogenic Mr. Hyde.  74:2506-2512. 2006
  • Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.  74:2809-2816. 2006
  • Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins.  74:1828-1836. 2006
  • Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.  74:1171-1180. 2006
  • Multifunctional role of choline binding protein G in pneumococcal pathogenesis.  74:821-829. 2006
  • β-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.  73:7827-7835. 2005
  • Aggravated lyme carditis in CD11a-/- and CD11c-/- mice.  73:7637-7643. 2005
  • In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: Role of granulocyte-macrophage colony-stimulating factor.  73:7450-7457. 2005
  • Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.  73:6399-6406. 2005
  • Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica serovar typhimurium to potentiate mucosal and systemic responses.  73:6763-6770. 2005
  • Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.  73:6892-6902. 2005
  • Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of Kala-Azar patients from Bihar, India.  73:7018-7021. 2005
  • Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.  73:6945-6951. 2005
  • Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B.  73:3990-3998. 2005
  • The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers..  73:3018-3024. 2005
  • Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.  73:1304-1312. 2005
  • Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.  73:1006-1013. 2005
  • Monoacyl lipoteichoic acid from pneumococci stimulates human cells but not mouse cells.  73:834-840. 2005
  • Association of a major protein antigen of Mycoplasma arthritidis with virulence.  73:245-249. 2005
  • Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by gram-negative bacteria.  73:532-545. 2005
  • Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040)).  72:7379. 2004
  • Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility and role in protection from superoxide.  72:5858-5867. 2004
  • Microarray analysis of pneumococcal gene expression during invasive disease.  72:5582-5596. 2004
  • Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar typhimurium and its cloned antigen.  72:5824-5831. 2004
  • PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin.  72:5031-5040. 2004
  • Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalis.  72:637-644. 2004
  • Effects of PspA and Antibodies to PspA on Activation and Deposition of Complement on the Pneumococcal Surface.  72:114-122. 2004
  • Sialylation of Lipooligosaccharides Promotes Biofilm Formation by Nontypeable Haemophilus influenzae.  72:106-113. 2004
  • Pneumococcal Surface Protein A Is Expressed in Vivo, and Antibodies to PspA Are Effective for Therapy in a Murine Model of Pneumococcal Sepsis.  71:7149-7153. 2003
  • Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.  71:5541-5548. 2003
  • Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.  71:4780-4788. 2003
  • Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae.  71:4498-4505. 2003
  • Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A.  71:2498-2507. 2003
  • Effects of zinc deficiency and pneumococcal surface protein A immunization on zinc status and the risk of severe infection in mice.  71:2009-2013. 2003
  • CD14- and toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.  71:1470-1480. 2003
  • Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.  71:1033-1041. 2003
  • Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.  71:75-85. 2003
  • Feasibility of an HA2 domain-based periodontitis vaccine.  71:562-566. 2003
  • Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.  71:218-225. 2003
  • Construction of a novel transposon mutagenesis system useful in the isolation of streptococcus parasanguis mutants defective in Fap1 glycosylation.  70:6534-6540. 2002
  • Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.  70:7042-7049. 2002
  • Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.  70:6779-6787. 2002
  • Vaginal and oral epithelial cell anti-Candida activity.  70:7081-7088. 2002
  • Increased host resistance against Pneumocystis carinii pneumonia in γδ T-cell-deficient mice: Protective role of gamma interferon and CD8+ T cells.  70:5208-5215. 2002
  • Susceptibility of nontypeable Haemophilus influenzae to human β-defensins is influenced by lipooligosaccharide acylation.  70:5287-5289. 2002
  • Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: An htrB mutation diminishes the colonization of human airway epithelial cells.  70:4661-4668. 2002
  • Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.  70:3557-3565. 2002
  • Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains.  70:2512-2518. 2002
  • Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.  70:2526-2534. 2002
  • Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine.  70:1965-1970. 2002
  • Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.  70:1724-1738. 2002
  • Identification and characterization of a nonimmunoglobulin factor in human saliva that inhibits Streptococcus mutans glucosyltransferase..  70:1136-1142. 2002
  • Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans.  70:577-583. 2002
  • Streptococcus pneumoniae PstS production is phosphate responsive and enhanced during growth in the murine peritoneal cavity.  69:7565-7571. 2001
  • Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.  69:6604-6611. 2001
  • Intranasal vaccination with pneumococcal surface protein A and Interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.  69:6718-6724. 2001
  • Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.  69:7091-7099. 2001
  • Resistance of T-cell receptor δ-chain-deficient mice to experimental Candida albicans vaginitis.  69:7162-7164. 2001
  • Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.  69:7178-7181. 2001
  • Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.  69:6401-6410. 2001
  • Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.  69:4870-4873. 2001
  • Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4+ T cells.  69:4486-4492. 2001
  • Requirement for capsule in colonization by Streptococcus pneumoniae.  69:3755-3761. 2001
  • Characterization of binding of human lactoferrin to pneumococcal surface protein A.  69:3372-3381. 2001
  • Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.  69:3335-3342. 2001
  • Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae.  69:2309-2317. 2001
  • Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.  69:2154-2161. 2001
  • Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.  69:336-344. 2001
  • Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4+ T cells.  69:252-261. 2001
  • Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae..  69:613-616. 2001
  • Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis.  68:7186-7189. 2000
  • Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638..  68:6411-6418. 2000
  • Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen..  68:5509-5516. 2000
  • Genetic characterization of a Streptococcus mutans LraI family operon and role in virulence.  68:4441-4451. 2000
  • Regulation of Brucella abortus catalase.  68:3861-3866. 2000
  • Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.  68:3028-3033. 2000
  • Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes.  68:1441-1449. 2000
  • Construction and characterization of a Salmonella enterica serovar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter.  68:1549-1556. 2000
  • Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.  68:511-517. 2000
  • Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries.  68:543-549. 2000
  • Effects of reproductive hormones on experimental vaginal candidiasis.  68:651-657. 2000
  • Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.  68:796-800. 2000
  • Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.  68:5509-5516. 2000
  • Comparative analysis of the mucosal adjuvanticity of the type II heat- labile enterotoxins LT-IIa and LT-IIb.  68:281-287. 2000
  • Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae.  68:5889-5900. 2000
  • Human C-reactive protein is protective against fatal Salmonella enterica serovar Typhimurium infection in transgenic mice.  68:5652-5656. 2000
  • Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.  68:5778-5784. 2000
  • Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties.  68:6082-6086. 2000
  • Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.  67:6249-6256. 1999
  • Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase.  67:6543-6549. 1999
  • Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination.  67:6341-6345. 1999
  • The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.  67:6533-6542. 1999
  • Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139.  67:6346-6349. 1999
  • Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate..  67:539-545. 1999
  • A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses.  67:618-623. 1999
  • Analysis of vaginal cell populations during experimental vaginal candidiasis.  67:3135-3140. 1999
  • Erratum: Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid (Infection and Immunity (1998) 66:12 (6010-6013)).  67:2051. 1999
  • Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I.  67:810-816. 1999
  • Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.  67:4352-4359. 1999
  • Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.  67:3937-3946. 1999
  • Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium.  67:4895-4901. 1999
  • Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.  67:4720-4724. 1999
  • Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.  67:3019-3025. 1999
  • Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B.  67:1172-1179. 1999
  • Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.  67:595-601. 1999
  • Virulence of a spaP mutant of Streptococcus mutans in a gnotobiotic rat model.  67:1201-1206. 1999
  • Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types..  66:4748-4754. 1998
  • A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein a induces protective responses against Streptococcus pneumoniae.  66:3744-3751. 1998
  • Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization..  66:1740-1743. 1998
  • Cytokine Involvement in Immunomodulatory Activity Affected by Candida albicans Mannan.  66:1384-1391. 1998
  • Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans.  66:5630-5635. 1998
  • Differences in the Frequency of Cytokine-Producing Cells in Antigenemic and Nonantigenemic Individuals with Bancroftian Filariasis.  66:1377-1383. 1998
  • Effect of lipopolysaccharide and inflammatory cytokines on interleukin- 6 production by healthy human gingival fibroblasts.  66:608-614. 1998
  • Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.  66:4299-4304. 1998
  • Enhanced Protective Antibody Responses to PspA after Intranasal or Subcutaneous Injections of PspA Genetically Fused to Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-2.  66:1513-1520. 1998
  • Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease- inhibitory activity in human female genital infection with Neisseria gonorrhoeae.  66:5826-5832. 1998
  • Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.  66:2743-2749. 1998
  • Identification of a Chlamydia trachomatis serovar e urogenital isolate which lacks the cryptic plasmid.  66:6010-6013. 1998
  • Inactivation of the gbpA gene of Streptococcus mutans increases virulence and promotes in vivo accumulation of recombinations between the glucosyltransferase B and C genes.  66:2180-2185. 1998
  • Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.  66:839-842. 1998
  • Roles of innate and adaptive immunity in respiratory mycoplasmosis.  66:3485-3491. 1998
  • Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor.  66:3443-3446. 1998
  • The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide.  66:4690-4695. 1998
  • Validation of a volunteer model of cholera with frozen bacteria as the challenge.  66:1968-1972. 1998
  • Promoter activities in Vibrio cholerae ctx phi prophage..  65:1561-1565. 1997
  • Avirulence of LT2 strains of Salmonella typhimurium results from a defective rpoS gene.  65:2451-2453. 1997
  • Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.  65:2278-2282. 1997
  • Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.  65:4701-4704. 1997
  • Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.  65:1237-1244. 1997
  • Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes.  65:3248-3254. 1997
  • Expression of thin aggregative fimbriae promotes interaction of Salmonella typhimurium SR-11 with mouse small intestinal epithelial.  65:5320-5325. 1997
  • Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.  65:1445-1454. 1997
  • Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.  65:640-644. 1997
  • Characterization of PepB, a group B streptococcal oligopeptidase.  64:3401-3406. 1996
  • Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.  64:1290-1298. 1996
  • Helicobacter pylori cytotoxin induces vacuolation of primary human mucosal epithelial cells.  64:4867-4871. 1996
  • Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.  64:1495-1501. 1996
  • Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin.  64:665-667. 1996
  • Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes.  64:1161-1165. 1996
  • Resistance to mycoplasmal lung disease in mice is a complex genetic trait.  64:5326-5331. 1996
  • Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.  64:4850-4853. 1996
  • Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit.  64:1272-1283. 1996
  • Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars.  64:2839-2841. 1996
  • The predicted amino acid sequence of the Salmonella typhimurium virulence gene mviA+ strongly indicates that MviA is a regulator protein of a previously unknown S. typhimurium response regulator family.  64:2365-2367. 1996
  • Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats..  63:2004-2011. 1995
  • A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.  63:448-455. 1995
  • Different forms of Streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: Cleavage by streptococcal cysteine protease.  63:2776-2779. 1995
  • Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.  63:2989-2994. 1995
  • Suppressive effect of interleukin-4 neutralization differs for granulomas around Schistosoma mansoni eggs injected into mice compared with those around eggs laid in infected mice.  63:2532-2536. 1995
  • The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.  63:4219-4223. 1995
  • Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats..  62:3162-3171. 1994
  • Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti.  62:1901-1908. 1994
  • Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.  62:2426-2431. 1994
  • Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.  62:1813-1819. 1994
  • Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.  62:1593-1599. 1994
  • Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes.  62:1867-1874. 1994
  • Role of M protein in pharyngeal colonization by group A streptococci in rats..  61:2277-2283. 1993
  • Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.  61:48-55. 1993
  • Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type B capsular polysaccharide.  61:5345-5350. 1993
  • Effects of Escherichia coli and E. coli lipopolysaccharides on the function of human ureteral epithelial cells cultured in serum-free medium.  61:3304-3312. 1993
  • Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: Mode of action and augmenting effect of inflammatory cytokines.  61:4637-4644. 1993
  • Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.  61:2162-2171. 1993
  • Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis.  61:3123-3128. 1993
  • Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.  61:3175-3183. 1993
  • Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.  61:4272-4279. 1993
  • Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.  61:1964-1971. 1993
  • Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.  61:384-390. 1993
  • Cholera toxin as a mucosal adjuvant: Effects of H-2 major histocompatibility complex and lps genes.  60:2874-2879. 1992
  • Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity.  60:5190-5196. 1992
  • Humoral response to Porphyromonas (Bacteroides) gingivalis in rats: Time course and T-cell dependence.  60:3579-3585. 1992
  • Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.  60:1957-1962. 1992
  • Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.  60:3986-3993. 1992
  • Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates.  60:3472-3474. 1992
  • Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.  60:111-116. 1992
  • A 43-kilodalton pneumococcal surface protein, PspA: Isolation, protective abilities, and structural analysis of the amino-terminal sequence.  59:1285-1289. 1991
  • Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.  59:852-856. 1991
  • PspA, a surface protein of Streptococcus pneumonia, is capable of eliciting protection against pneumococci of more than one capsular type.  59:222-228. 1991
  • Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid.  58:2547-2554. 1990
  • Activation of cholera toxin-specific T cells in vitro.  58:3711-3716. 1990
  • Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigen.  58:2785-2791. 1990
  • Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.  58:3487-3493. 1990
  • Liposomes containing anti-idiotypic antibodies: An oral vaccine to induce protective secretory immune response specific for pathogens of mucosal surfaces.  58:1932-1936. 1990
  • Molecular characterization of the Clostridium difficile toxin A gene.  58:480-488. 1990
  • Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.  58:3293-3299. 1990
  • Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.  58:3073-3077. 1990
  • Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid.  58:2309-2312. 1990
  • Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.  57:1457-1464. 1989
  • Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.  57:2037-2042. 1989
  • Ureaplasma urealyticum pneumonia: Experimental production and demonstration of age-related susceptibility.  57:918-925. 1989
  • A pneumococcal surface protein (PspB) that exhibits the same protease sensitivity as streptococcal R antigen.  56:3001-3003. 1988
  • Analysis of the virulence of Streptococcus mutans serotype c gtfA mutants in the rat model system.  56:322-330. 1988
  • Fungal-strain-dependent alterations in the time course and mortality of chronic murine pulmonary blastomycosis.  56:34-39. 1988
  • Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: Implications for natural transmission.  56:3216-3220. 1988
  • Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein.  55:3065-3069. 1987
  • Association and dissociation of Escherichia coli heat-stable enterotoxin from rat brush border membrane receptors.  55:329-334. 1987
  • Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptocococcus mutans.  55:2341-2347. 1987
  • Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes.  54:780-786. 1986
  • Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans.  53:317-323. 1986
  • Plasmid-determined cytotoxicity in Yersinia pestis and Yersinia pseudotuberculosis.  51:788-794. 1986
  • Salivary immunoglobulin A and serum antibodies to Streptococcus mutans ribosomal preparations in dental caries-free and caries-susceptible human subjects.  51:348-351. 1986
  • Salmonella typhimurium virulence genes necessary to exploit the Ity(s/s) genotype of the mouse.  51:872-878. 1986
  • Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins.  48:813-817. 1985
  • Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids.  48:51-56. 1985
  • Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens.  49:459-462. 1985
  • Inhibition of plaque and caries formation by a glucan produced by Streptococcus mutans mutant UAB108.  50:833-843. 1985
  • The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.  50:392-397. 1985
  • Function of anti-Streptococcus mutans antibodies: Anti-ribosomal antibodies inhibit acid production, growth, and glucose phosphotransferase activity.  45:286-289. 1984
  • Lack of cross-reactivity of antibodies to ribosomal preparations from Streptococcus mutans with human heart and kidney antigens.  46:42-47. 1984
  • Effective immunity to dental caries: Enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants.  40:577-591. 1983
  • Effective immunity to dental caries: Gastric intubation of Streptococcus mutans whole cells or cell walls induces protective immunity in gnotobiotic rats.  39:645-654. 1983
  • Immunoglobulin A-mediated hepatobiliary transport constitutes an natural pathway for disposing of bacterial antigens.  42:1041-1048. 1983
  • In vitro and in vivo complementation of Streptococcus mutans mutants defective in adherence.  42:558-566. 1983
  • Transformed and normal cell surface glycoproteins that induce interferon production by nonsensitized lymphocytes.  39:220-224. 1983
  • Antigenic analysis of Giardia lamblia from Afghanistan, Puerto Rico, Ecuador, and Oregon.  36:714-719. 1982
  • Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: Immunological and histopathological parameters.  35:685-696. 1982
  • Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.  36:184-188. 1982
  • Cell-produced viral inhibitor: Possible mechanism of action and chemical composition.  32:454-457. 1981
  • Human B lymphocytes produce leukocyte interferon after interaction with foreign cells.  32:508-512. 1981
  • Interference of secretory immunoglobulin A with sorption of oral bacteria to hydroxyapatite.  31:942-951. 1981
  • Oral ecology and virulence of Lactobacillus casei and Streptococcus mutans in gnotobiotic rats.  33:690-696. 1981
  • Phagocytosis and killing of Salmonella typhimurium by peritoneal exudate cells.  33:380-388. 1981
  • Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.  34:166-170. 1981
  • Virulence of Streptococcus mutans: Characterization of a serotype g antigen-defective mutant and its revertants.  31:151-159. 1981
  • Effects of cyclophosphamide on murine candidiasis.  27:376-386. 1980
  • Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.  27:140-149. 1980
  • Interferon immunosuppression: Mediation by a suppressor factor.  29:301-305. 1980
  • Transfer of interferon-induced viral resistance from human leukocytes to other cell types.  29:356-360. 1980
  • Virulence of Streptococcus mutans: Immunochemical characterization of a serotype g-defective mutant (C307).  27:697-699. 1980
  • Virulence of Streptococcus mutans: In vivo reversion of a low-virulence mutant results in partial displacement and pathogenesis.  27:1003-1011. 1980
  • Virulence of Streptococcus mutans: Restoration of pathogenesis of a glucosyltransferase-defective mutant (C4).  27:915-921. 1980
  • Cellular interactions determine the rate and degree of interferon action.  23:496-501. 1979
  • Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease.  26:143-149. 1979
  • Effective immunity to dental caries: dose-dependent studies of secretory immunity by oral administration of Streptococcus mutans to rats.  19:217-224. 1978
  • Experimental murine candidiasis: Pathological and immune responses in T-lymphocyte-depleted mice.  21:729-737. 1978
  • Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.  20:88-98. 1978
  • Isolation of glycopeptides with skin test activity from dermatophytes..  19:1031-1046. 1978
  • Leukocytic endogenous mediator in Crohn's disease.  22:637-639. 1978
  • Effective immunity to dental caries: passive transfer to rats of antibodies to Streptococcus mutans elicits protection.  17:644-650. 1977
  • Low sucrose levels promote extensive Streptococcus mutans induced dental caries.  16:712-714. 1977
  • Virulence of Streptococcus mutans: cariogenicity of S. mutans in adult gnotobiotic rats.  15:466-471. 1977
  • Effective immunity to dental caries: protection of malnourished rats by local injection of Streptococcus mutans.  13:782-789. 1976
  • Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva.  14:355-362. 1976
  • Effect of Tween 80 and Aquasol A on virus plaque formation.  12:490-494. 1975
  • Virulence of Streptococcus mutans: a sensitive method for evaluating cariogenicity in young gnotobiotic rats.  12:69-75. 1975
  • Role of the vegetation in experimental Streptococcus viridans endocarditis.  10:1433-1438. 1974
  • Interaction of virulent and avirulent Listeria monocytogenes with cultured mouse peritoneal macrophages..  7:409-415. 1973
  • International Standard Serial Number (issn)

  • 0019-9567
  • Electronic International Standard Serial Number (eissn)

  • 1098-5522